Citing Dutch team again, “concerns have been raised that blocking treatment itself may increase the persistence of gender dysphoria”, but adds that we don’t know this yet.

Medium and long terms consequences of starting blocker treatment, it’s argued, include:
Inability to orgasm, compromised cognitive function, lifelong need for medication, repeated surgical intervention.

Case being made by Bell is that the blocker is not fully physically reversible, as claimed.

Nor do claimants believe that no young person should have access to blockers.

While young people who want them should have access to blockers, it’s argued, it’s right that the court should be able to intervene if it is in their best interests.

Claimants do not question existence of GD, nor do they question that those who suffer from it experience sever distress

Involving the court in the decision for puberty blockers, they argue, does not undermine the autonomy of young people

Barrister arguing that the claimants do not believe these young people are “sufficiently mature enough to understand the effects of these drugs.”

Tavistock reported in April 2020, 161 referrals to Endocronology. Ave age 15.4 years. Youngest 10 years old, 26 were 13 or under